Thursday, February 2, 2012

Football head injuries: Testimony

1
Written Testimony
Ann C. McKee, M.D.
Associate Professor of Neurology and Pathology
Boston University School of Medicine
Director of the VISN-1 Neuropathology Laboratory for the New England Veterans
Administration Medical Centers
Director of the Brain Banks for the Boston University Alzheimer’s Disease Center,
Framingham Heart Study, and Centenarian Study
Co-Director, Center for the Study of Traumatic Encephalopathy
Hearing before the House Judiciary Committee
Legal Issues Relating to Football Head Injuries
October 28, 2009
2
3
Mr. Chairman and Members of the Committee:
Thank you for the invitation to testify today on legal issues relating to football head
injuries. My name is Dr. Ann McKee. I am an associate professor of Neurology and
Pathology at Boston University School of Medicine, and I am the Director of the
Neuropathology Laboratory for the New England Veterans Administration Medical
Centers at the Bedford VA Medical Center, the Director of the Brain Banks for the
Boston University Alzheimer’s Disease Center, the Framingham Heart Study, and the
Centenarian Study, and I am a co-director for the Center for the Study of Traumatic
Encephalopathy at Boston University.
I received my medical degree in 1979, and I am board certified in both Neurology and
Neuropathology. I have extensive experience in neuropathology of neurological disease
and have written extensively on the neuropathology of many neurodegenerative
diseases, including Alzheimer’s disease, Parkinson’s disease, and Frontotemporal
Dementia, as well as normal aging. For the past 23 years, I have been studying the
brains of individuals after death and correlating the pathological findings to the patient’s
clinical symptoms during life. I have examined thousands of brains, brains from people in
all walks of life including brains from individuals who have lived to be well over the age of
100. In addition, for most of my professional career, I have been focused on tau protein,
a protein that becomes toxic when abnormally phosphorylated and builds up in the
brains of patients with some neurodegenerative diseases, including Alzheimer’s disease,
but is found only in very limited quantities in the brains of normally functioning people.
In January of 2003, as part of my work with the Boston University Alzheimer’s Disease
Center and the Bedford VA, I examined the brain of a man who died at the age of 72
after 15 years of severe dementia requiring institutionalization. The man had been a
4
world champion boxer and had been clinically diagnosed with Alzheimer’s disease
beginning at the age of 58. However, when I looked at his brain on post-mortem
examination, I found that there was absolutely no evidence of Alzheimer’s disease;
there was no evidence of beta amyloid, a protein that accumulates in the brain in people
with Alzheimer’s disease and is thought by many to be the cause of Alzheimer’s disease.
Instead, the brain of this world champion boxer showed a massive build-up of the toxic
form of tau protein as neurofibrillary tangles (NFTs) and glial tangles throughout his
brain. The neurofibrillary and glial tangles were also distributed in a unique pattern, a
pattern not found in any neurodegenerative condition except Chronic Traumatic
Encephalopathy, or CTE. In CTE, tau protein builds up in individual nerve cells and
prevents them from making normal connections with other nerve cells, eventually killing
the cells. In this man’s brain, there were massive numbers of NFTs and glial tangles, so
many in fact that you could see the abnormalities on the glass slides without the use of a
microscope, as you can see in the right panels of Figure 1. There is tremendous
accumulation of tau protein that appears as a brown pigment. All the brown pigment you
see is abnormal, please compare what you see on the right to the brain of a normal 65
year old man on the left, all the slides are prepared and stained in exactly the same way,
and there is absolutely no brown pigment visible in the normal individual. When you look
at the brain microscopically as in the lower panels, you can see that many individual
nerve cells of the boxer contain NFTs – they are found in nearly every nerve cell and
there are almost no normal appearing cells. This individual, a former professional boxer,
was clinically diagnosed with Alzheimer’s disease during life, but the disease that
actually caused his tragic 15 year decline in intellect and eventually killed him, was CTE,
a disorder that would have been entirely prevented if he hadn’t suffered repeated head
injury in his younger years as a boxer.
5
My second case of CTE came in 2004, again when I was examining the brain of a man
who had been clinically diagnosed with Alzheimer’s disease when he was alive. When I
looked at the slides, I immediately realized that the changes found in this individual were
nearly identical to those that I had found in the world champion boxer, but in this case,
the medical records did not indicate that he had ever had any head injury. So I called the
patient’s daughter, and sure enough, it turned out that the man had been a professional
boxer during his twenties. Again, his post-mortem examination indicated that his
functional deterioration, dementia and placement in a nursing home were not due to
Alzheimer’s disease, but instead due to CTE, a disorder that could have been entirely
prevented. Over the ensuing years, I examined several other cases of CTE in
professional boxers, all with a similar appearance and pattern of abnormalities.
I met Chris Nowinski in the summer of 2007 and through Chris’s efforts in early 2008, I
had my first opportunity to examine the brain of a retired professional football player. It
was the brain of John Grimsley, a former linebacker for the Houston Oilers who had died
of an accidental gunshot wound while cleaning his gun at the age of 45. According to his
wife, he was concussed 3 times during his college football years, and at least 8 times
during his NFL career, however, only one "cerebral concussion" was medically
confirmed. He was never formally diagnosed with post-concussion syndrome and never
sought medical attention for residual cognitive and behavioral difficulties. There was no
history of ever losing consciousness for more than a few seconds and he never required
being carried off the field or hospitalization. He never took any performance-enhancing
drugs or used illicit drugs. He was a nonsmoker and there was no known family history
of dementia.
6
According to his wife and close friends, he began showing changes in his behavior and
cognitive decline at age 40. He developed difficulties in short-term memory, attention,
concentration, organization, planning, problem-solving, judgment, and the ability to
juggle more than one task at a time. For example, he would ask the same questions
repeatedly over the course of the day and he would ask to rent a movie that he had
already seen. He had difficulty assembling his tax records, shopping alone, and
understanding television. His symptoms gradually progressed and became quite severe
by the end of his life. He also developed a “shorter and shorter fuse” and would become
angry and verbally aggressive over seemingly trivial issues.
When I first looked at his brain (it had been previously dissected by the coroner), I didn’t
see any gross changes. Yet when the microscopic slides were prepared, they showed
the exact same pattern of changes that I had found in the brains of the boxers with CTE.
There were large numbers of tau containing neurofibrillary tangles throughout all parts of
the brain and there was absolutely no evidence of beta amyloid protein or Alzheimer’s
disease. The brain of this 45 year old husband and father, at the prime of his life,
showed profound neurofibrillary degeneration, changes of CTE that were identical in
nature to the changes I found in the brains of the boxers, but were now in a football
linebacker some 30 years younger. In John Grimsley’s brain, there were striking
changes in regions of the brain controlling personality and behavior, such as the frontal
lobes, profound changes in the areas controlling impulsivity and rage behavior such as
the amygdala, and severe changes in anatomic structures that are responsible for
memory, such as the hippocampus, mammillary bodies and thalamus. In Figure 1, the
brain of John Grimsley is seen in the middle; in the top middle panel, you can see severe
tau deposition in the frontal lobe and microscopically; in the bottom middle panel, you
can see numerous nerve cells containing tau and NFTs.
7
Figure 1
In a normal 45 year old, absolutely none of these changes would be found. Indeed these
changes would not be found in a normal 65 year old, 85 year old or 110 year old.
8
The next football player’s brain that I examined was that of Tom McHale, a 45 year old
retired offensive lineman for the Tampa Bay Buccaneers. He was a husband and father
of 3 young boys. After a 3 year decline in his ability to make sound business decisions,
increasing apathy, depression, and memory loss, he died as a result of substance
abuse. His wife did not know of any reported formal concussions during his year as a
lineman. His brain too showed profound tau immunoreactive neurofibrillary
degeneration in areas controlling memory, impulsivity, organization and problem solving
(as you can see in Figure 2) and again with no evidence of any other disorder other than
CTE.
Figure 2
The third brain of a professional football player I examined was that of Wally Hilgenberg,
a 66 year old former linebacker who died from complications related to Amyotrophic
Lateral sclerosis or Lou Gehrigs disease. He played 16 seasons with the Minnesota
Vikings and had at least 10 concussions, including losing consciousness on 1 or 2
occasions. He began showing slow and steady cognitive decline at the age of 56. His
cognitive difficulties were manifest mainly by “not understanding things at a deeper level”
and he had difficulties with executive functioning, including worsening organization and
9
planning skills. His cognitive decline progressed with worsening memory and language
functions. In his last year, he stopped being able to read and was completely unable to
learn how to operate an assistive communication device, even using the simplest level of
commands. Inspection of his brain showed damage to the frontal cortex in a pattern that
suggested it had been used as a battering ram, and the interior spinal fluid spaces were
enlarged suggesting that the volume of the brain had declined. Microscopically the brain
was densely riddled by tau containing NFTs and glial tangles throughout the cerebral
cortex, basal ganglia, thalamus, and brainstem in the unique pattern that defines CTE,
and again, in the complete absence of Alzheimer’s disease and beta amyloid.
Furthermore, the damage found in his brain was far greater in density and the damage
was much more widespread than anything that I have ever found in Alzheimer’s disease
or any of the other common neurodegenerative disorders.
Figure 3
10
The fourth, fifth and sixth brains from former NFL football players that I examined,
including one individual who took his own life, all showed the same distinctive,
characteristic changes of CTE. The seventh brain of a former NFL player I analyzed was
that of Louis Creekmur, a former offensive lineman for the Detroit Lions and an eighttime
Pro Bowler. Louis Creekmur played ten seasons for the Lions, and was famous for
suffering at least thirteen broken noses and 16 concussions. Beginning at the age of 58,
he began to show increasing cognitive and behavioral difficulties including memory loss,
problems with attention and organization, and outbursts of anger and aggression. He
died from complications of dementia at the age of 82. The brain of Mr. Creekmur showed
extensive damage including marked shrinkage of medial temporal lobe structures that
control memory, shrinkage of the frontal and temporal lobes, and marked dilation of the
spinal fluid cavities that line the brain’s interior. There was widespread and severe tau
deposition as NFTs throughout the frontal and temporal lobes, amygdala, hippocampus,
thalamus and brainstem in the unique pattern that is only found in CTE. In Mr.
Creekmur’s case, the abnormalities were profound, they were severe, and they
paralleled the changes found in the world champion professional boxer. Mr. Creekmur
was also a member the NFL’s Plan 88. Yet again, there was absolutely no evidence of
Alzheimer’s disease or any other neurodegenerative disorder, and the findings indicated
that if Mr. Creekmur had not sustained repetitive head trauma during the play of football,
he would be alive and well and enjoying his family and grandchildren today.
11
Figure 4
I have also examined the brain of a former college football player, Mike Borich, a former
wide receiver for Snow College and Western Illinois University who died at the age of 42
after a several-year period of increasing irritability, aggressive and violent outbursts, and
drug and alcohol abuse. His brain, too, showed CTE affecting widespread parts of his
cerebral cortex and deep brain nuclei. Brains from 3 other college football players
showed similar changes.
Lastly, I have had the opportunity to examine the brain of a high school football player
who died at the age of 18. He had played football and other sports for 4 years and
suffered several concussions. The brain of an 18 year old should be pristine, there
should be no abnormalities anywhere, no abnormalities whatsoever. But in the brain of
this young man, a brain that should be entirely normal, there were spots of undeniable
pathology. They were 4 areas of damage in the frontal lobe that you could see even
looking at the slides with your naked eye (Figure 5). In those areas, there were hundreds
of degenerating nerve cells containing tau neurofibrillary tangles and disordered nerve
12
cell processes. Even in this 18 year old high school student, with only a few years
experience playing football, there were signs of the earliest stages of CTE. Had he lived
longer, this 18 year old would have almost certainly developed the same full blown CTE
that we found in the other college and professional football players.
Figure 5
I have now examined the brains of 7 former NFL players, and 4 college layers, and all 11
have shown profound and widespread changes of CTE. I have also found CTE in a
college level player and the earliest signs of CTE in a high school football player. I
realize that this is just a handful of cases, so – so what? -what can you say from just 11
cases? Well, I can say that for the past 23 years, I have looked at thousands of brains,
from individuals from all walks of life, of all ages, and during the past 20 years, I have
primarily focused on abnormalities of tau protein. But I have only seen this unique
13
pattern of changes, in this severity, in individuals with a history of repetitive head trauma,
including boxers and football players. These changes are dramatically not normal -there
is no way these pathological changes represent a variation in normal that we find under
a bell shaped curve. We have found these changes in every professional football
players’ brain that has come into my laboratory at the BU Center for the Study of
Traumatic Encephalopathy and I have never seen this in 20 plus years of examining
brains. I have had colleagues of mine from other institutions – leading neuropathologists
from Harvard and Mt. Sinai—independently examine these brains, and they have come
up with the same diagnosis as I had, CTE. I know that the argument is often made that
there are hundreds of thousands of former football players, including former professional
football players, with no signs of any cognitive decline or memory loss or personality
change, but what I don’t understand is why are we expecting that this exposure to
repetitive head trauma will have 100% penetrance into the population and cause disease
in every football player? Do we expect 100% of cigarette smokers will develop lung
cancer? Do we expect 100% of children who play with matches or even chain saws will
get hurt? No. Even if the percentage of affected players is 20%, or 10%, there are still
thousands of kids and adults out there, right now, playing football at all levels -who will
eventually come down with this devastating and debilitating disorder. And as a doctor
and as a mother, I think this calls for immediate action. We need to take radical steps to
change the way football is played and we need to make those changes today.
14
B.U. Center for the Study of Traumatic Encephalopathy Grant Support
Title: Development of Pathology Diagnostic Criteria for Chronic Traumatic
Encephalopathy
Co-Principal Investigators: Ann McKee and Robert Stern
Type of Grant: Supplement to P30 Center Grant (N. Kowell, P.I); P30-AG13846
Funding Agency: National Institute on Aging
Years Funded: 2009-2010
Total Direct Costs: $83,287
Title: Neuropathologic Examination of Traumatic Encephalopathy in Athletes with
Histories of Repetitive Concussion
Co-Principal Investigators: Ann McKee and Robert Stern
Type of Grant: Supplement to P30 Center Grant (N. Kowell, P.I); P30-AG13846
Funding Agency: National Institute on Aging
Years Funded: 2008-2009
Total Direct Costs: $100,000

Low pressure hyperbaric oxygen therapy and SPECT brain imaging

Case report
Open Access
Low pressure hyperbaric oxygen therapy and SPECT brain imaging
in the treatment of blast-induced chronic traumatic brain injury
(post-concussion syndrome) and post traumatic stress disorder:
a case report
Paul G Harch1*, Edward F Fogarty2, Paul K Staab1 and Keith Van Meter1
Addresses: 1Section of Emergency Medicine, Department of Medicine, Louisiana State University Health Sciences Center, 2021 Perdido St, Room
W535, New Orleans, Louisiana, 70112, USA and 2Department of Radiology, University of North Dakota School of Medicine and Health Sciences,
Post Office Box 1975, 515 ½ East Broadway Avenue, Suite 106, Bismarck, North Dakota, 58502, USA
Email: PGH* - paulharchmd@aol.com; EFF - efogarty@medicine.nodak.edu; PKS - pstaab@wjmc.org; KVM - kvanmeter@aol.com
* Corresponding author
Published: 5 June 2009 Received: 12 March 2009
Accepted: 4 April 2009
Cases Journal 2009, 2:6538 doi: 10.4076/1757-1626-2-6538
This article is available from: http://casesjournal.com/casesjournal/article/view/6538
© 2009 Harch et al; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
A 25-year-old male military veteran presented with diagnoses of post concussion syndrome and post
traumatic stress disorder three years after loss of consciousness from an explosion in combat. The
patient underwent single photon emission computed tomography brain blood flow imaging before
and after a block of thirty-nine 1.5 atmospheres absolute hyperbaric oxygen treatments. The patient
experienced a permanent marked improvement in his post-concussive symptoms, physical exam
findings, and brain blood flow. In addition, he experienced a complete resolution of post-traumatic
stress disorder symptoms. After treatment he became and has remained employed for eight
consecutive months. This case suggests a novel treatment for the combined diagnoses of blastinduced
post-concussion syndrome and post-traumatic stress disorder.
Introduction
By January, 2008 it was estimated that as many as 300,000
servicemen and women from the current Iraq and Afghanistan
Wars have PTSD or major depression, 320,000 have
experienced a TBI, and 82,000 have all three diagnoses [1].
Treatment is available for PTSD and depression, but there is
no proven therapy for the dual diagnoses of PTSD and the
residual effects of TBI, the PCS [2].
HBOT is the use of greater than atmospheric pressure
oxygen in an enclosed chamber to treat basic disease
processes [3]. HBOT has been traditionally applied to
certain emergent conditions and chronic wound conditions,
but not to blast-induced TBI/PCS or PTSD. This case
report is the first application of the authors’ low pressure
HBOT protocol for chronic brain injury to blast-induced
TBI/PCS and PTSD. An early version of this protocol was
recently reported in an animal model of chronic TBI that
duplicated the human experience [4].
Case presentation
A 25-year-old retired Caucasian male U.S. Marine presented
with headaches, tinnitus, and sleep disturbance.
Three years before evaluation the patient sustained LOC
Page 1 of 4
(page number not for citation purposes)
(a few minutes) from an IED explosion with anterograde
memory loss and confusion (one hour), and persistent
right ear tinnitus, headaches, imbalance, and sleep
disturbance. He developed PTSD symptoms within
3 months and experienced six more explosions with near
LOC within 15 months. After medical evaluation diagnoses
were TBI/PCS, PTSD, depression, hearing loss, and
tinnitus.
Prioritized Symptom List: 1) Constant headaches with
intermittent confusion, irritability, tunnel vision, and
dizziness, 2) Bilateral tinnitus, 3) Sleep disruption, 4) Left
eye blurred vision, 5) Irritability, 6) Depression, social
withdrawal; Additional Symptoms: 7) Fatigue, 8)
Decreased hearing, 9) Imbalance, 10) Cognitive problemsmemory,
attention, decreased speed of thinking, 11) Back
pain, 12) Bilateral knee pain, 13) PTSDsymptoms: intrusive
thoughts, combat thoughts, nightmares, tachycardia.
Med-Surg, Medications: None. FH, ROS, and PHIS: noncontributory
or negative. PSH: Engaged, no children, lives
with parents, 3 years college education, no tobacco or
drugs, one to two beers/week. Neuro PEx Abnormalities:
Slight deviation of right eye laterally, bilateral: decreased
hearing to softly rubbing fingers at one foot, noxious
response to 512 Hz tuning fork, decreased finger tapping
speed, unstable: rotation exam, tandem gait, and Romberg.
Treatment and testing: MRI brain-normal. SPECT
brain imaging pre-HBOT and 72 h after the 39th HBOT.
The patient underwent 39 HBOT’s in 26 calendar days at
1.5 ATA/60 minutes total dive time, twice/day, five days/
week in a monoplace chamber with 100% oxygen.
Outcome: Headache permanently gone after the 1st
HBOT. After 12 HBOT’s symptoms 3, 6, and 7 improved.
At 25th HBOT absence of PTSD symptoms. Re-evaluation
after 37 HBOT’s: 1) 4/6 primary problems improved
(#’s 1, 3, 5, 6), 2/6 no change, 2) 4/7 additional symptoms
improved (7, 9, 10, 13), 3/7 no change, 3) 6/6 abnormal
exam findings retested improved, 1 finding not retested
(right eye deviation). SPECT: heterogeneous with bilateral
frontal and temporal defects-all improved post HBOT. See:
Movie 1, Figures 1 and 2. (Movie 1): Side by side Pre and
Post HBOT processed transverse SPECT brain blood flow
images-movie. File Format: Quicktime Video. Description
of Data: Pre-HBOT scan is on the left and post-HBOT on
the right. Click on either image to initialize movie. Images
were obtained on a Picker Prism 3000 triple-head gamma
camera. Both scans were processed by technologist PJT:
25 mCi of ECD was prepared with the standard manufacturer’s
kit and injected in a peripheral vein in a low
noise low light area while the patient was quiet and
motionless. One hour after injection acquisition proceeded
with a 360 degree rotation and 40 stops,
20 seconds/stop on a 128 x 128 matrix, using low energy
high resolution fan beam collimators. Motion correction
was used for minor movement. Raw data was processed by
transverse reconstruction using 360 degree filtered back
projection and a ramp filter, followed by a LoPass filter,
order 2.2. Cutoff was taken at the intersection of the
best fit LoPass filter and noise on the power spectrum
graph. Per file attenuation correction and best fit ellipse
were applied. Images were oblique reformatted with slice
thickness at 4 mm (2 pixels), aligned, and off-center zoom
Figure 2. Post-HBOT SPECT brain scan three dimensional
surface reconstruction and processed transverse images.
Note relative improvement in brain blood flow to bilateral
focal frontal and temporal defects and overall normalization of
blood flow to a more homogeneous pattern.
Figure 1. Pre-HBOT SPECT brain scan three dimensional
surface reconstruction and processed transverse images.
Note bilateral orbital frontal and temporal lobe defects and
diffuse heterogeneous pattern of blood flow.
Page 2 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:6538 http://casesjournal.com/casesjournal/article/view/6538
applied (20 cm2 area). Images were presented in all
3 orthogonal planes. Transverse processed images were
analyzed with Osirix Open-source software (version 3.3.2)
and windowed at a level of 1000 with a window width of
2000. They were subsequently rendered in QuickTime
movie format starting from vertex and proceeding through
the base of the brain. Images are in standard SPECT format
and orientation. Color map is red, yellow, green, blue, and
violet from highest brain blood flow to lowest. Note the
marked generalized increase in perfusion on the post-
HBOT scan. (Figure 1): Pre-HBOT SPECT brain scan three
dimensional surface reconstruction and processed transverse
images. Pre-HBOT scan was rendered in three
dimensional surface reconstruction format by PJT based
on the method developed and taught by Picker International
using Picker software. In this method brain blood
flow is computer indexed to frontal lobe blood flow. A
frontal lobe surface defect was identified on a selected
transverse slice. Processed/filtered transverse slices were
then featured with a 100% window such that all pixels
render a white image. Counts were slowly subtracted by
decreasing the window threshold until the defect was
visible as a full thickness black defect in the contour of the
cortex. As the defect emerged and was registered in proper
anatomic proportion to the rest of frontal cortical blood
flow the numerical window level was taken as the
determination threshold. Three separate determinations
were made for each scan and the final threshold taken as
an average of the three determinations. The technologist
was blind to the final image reconstruction due to software
restrictions that only allow threshold determination. The
surface reconstruction image at this threshold is featured
in the image above. Color is aesthetic. Note bilateral
orbital frontal and temporal lobe defects, areas typically
injured in traumatic brain injury, consistent with processed
transverse images in the right hand columns.
Processed images also show an abnormal diffuse heterogeneous
pattern of blood flow. Description of processing
is in (Movie 1). (Figure 2): Post-HBOT SPECT brain scan
three dimensional surface reconstruction and processed
transverse images. Three dimensional surface image was
prepared in identical fashion to the image in Figure 1.
Note relative improvement in brain blood flow to bilateral
focal frontal and temporal defects, consistent with
processed transverse images in the right hand columns.
Transverse slices also show normalization of the blood
flow to a more homogeneous pattern.
Discussion
The present case is the first application of the author’s
HBOT protocol to blast-induced TBI/PCS and PTSD. The
patient’s symptomatic, physical exam, and SPECT
improvements are similar to ours [3,5,6,9] and others’
[7,8] previous cases/case series of non-blast TBI suggesting
common pathophysiology. The unexpected result was the
complete resolution of PTSD. With the overlap of
symptoms, pathophysiology, and anatomy in TBI/PCS
and PTSD [10] HBOT is likely impacting common shared
targets in this case.
Conclusion
Thirty-nine low pressure HBOT’s caused a reduction in
symptoms and signs of chronic mild-moderate blastinduced
TBI/PCS and PTSD. The resolution of symptoms
and signs of TBI/PCS and PTSD were reflected in global
and focal improvements in brain blood flow imaging,
suggesting a novel treatment for these combined
diagnoses.
Patient’s perspective
Patient has declined to submit his perspective due to
privacy concerns.
List of abbreviations
ATA, Atmospheres absolute; ECD, Ethyl cysteinate dimer;
FH, Family history; HBOT, Hyperbaric oxygen therapy;
HPI, History of present illness; IED, Improvised explosive
device; LOC, Loss of consciousness; MRI, Magnetic resonance
imaging; PCS, Post-concussion syndrome; PEx,
Physical exam; PHIS, Prior head injury history; PMH, Past
medical history; PSH, Personal and Social history; PTSD,
post-traumatic stress disorder; ROS, Review of systems;
SPECT, Single photon emission computed tomography;
TBI, Traumatic brain injury.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal. In addition,
this case was approved by the LSU School of Medicine’s
Institutional Review Board as a case report.
Competing interests
The authors declare competing interests. The primary
author has a small corporation, Harch Hyperbarics, Inc.
that does hyperbaric consulting. Author KVM has a
corporation that leases hyperbaric oxygen chambers and
a corporation that contracts to provide hyperbaric oxygen
and woundcare services. None of the authors have
personal or financial relationships with people or organizations
that would influence the interpretation of data in
this report.
Authors’ contributions
PGH evaluated the patient, ordered the treatment and
imaging, and wrote the draft of the manuscript. EFF
analyzed and presented the SPECT imaging and assisted in
writing the manuscript. PKS assisted in the treatment of
the patient and assisted in writing the manuscript. KVM
Page 3 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:6538 http://casesjournal.com/casesjournal/article/view/6538
assisted in development of the hyperbaric protocol and
writing the manuscript. All authors read and approved the
final manuscript.
Acknowledgements
The authors are indebted to nuclear technologist Philip J.
Tranchina for expert processing and three dimensional
thresholding of the SPECT brain imaging.
References
1. Tanielian T, Jaycox LH, Eds: Invisible Wounds of War: Psychological
and Cognitive Injuries, Their Consequences, and
Services to Assist Recovery. Center for Military Health Policy
Research, the Rand Corporation, Arlington, VA, 2008.
2. King NS: PTSD and traumatic brain injury: Folklore and fact?
Brain Injury 2008, 22:1-5.
3. Harch PG, Neubauer RA: Hyperbaric oxygen therapy in global
cerebral ischemia, anoxia, and coma. In The Textbook of
Hyperbaric Medicine, Chapter 18, 3rd Edition. Edited by Jain KK. Seattle,
Washington, Hogrefe and Huber; 1999:318-349.
4. Harch PG, Kriedt C, Van Meter KW, Sutherland RJ: Hyperbaric
oxygen therapy improves spatial learning and memory in a
rat model of chronic traumatic brain injury. Brain Res 2007,
1174:120-129.
5. Harch PG, Van Meter KW, Neubauer RA, Gottlieb SF: Use of
HMPAO SPECT for assessment of response to HBO in
ischemic/hypoxic encephalopathies. In The Textbook of Hyperbaric
Medicine. Chapter 35, Appendix 2. 2nd Edition. Edited by Jain KK.
Seattle, Washington, Hogrefe and Huber; 1996:480-491.
6. Harch PG, Neubauer RA: Hyperbaric oxygen therapy in global
cerebral ischemia/anoxia and coma. In The Textbook of Hyperbaric
Medicine. Chapter 18, 4th Revised Edition. Edited by Jain KK. Seattle,
Washington, Hogrefe & Huber; 2004:223-262.
7. Neubauer RA, Gottlieb SF, Pevsner NH: Hyperbaric oxygen
treatment of closed head injury. South Med J 1994, 87:933-936.
8. Golden ZL, Neubauer RA, Golden CJ et al.: Improvement in
cerebral metabol-ism in chronic brain injury after hyperbaric
oxygen therapy. Int J Neurosci 2002, 112:119-131.
9. Harch PG, Gottlieb SF, Van Meter KW, Staab P: HMPAO SPECT
brain imaging and low pressure HBOT in the diagnosis and
treatment of chronic traumatic, ischemic, hypoxic and
anoxic encephalopathies. Undersea & Hyperbaric Medicine 1994,
21:30.
10. Kennedy JE, Jaffee MS, Leskin GA et al.: Posttraumatic stress
disorder and posttraumatic stress disorder-like symptoms
and mild traumatic brain injury. J Rehab Res Devel 2007,
44:895-920.
Movie 1. Side by side Pre and Post HBOT processed
transverse SPECT brain blood flow images-movie. Click on
this link to activate the video: http://casesjournal.com/
casesjournal/article/downloadFile/6538/303311
Page 4 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:6538 http://casesjournal.com/casesjournal/article/view/6538
Do you have a case to share?
Submit your case report today
• Rapid peer review
• Fast publication
• PubMed indexing
• Inclusion in Cases Database
Any patient, any case, can teach us
something
www.casesnetwork.com

Vitamins & Healthy Fats Promote Mental Acuity

Vitamins & Healthy Fats Promote Mental Acuity

Posted on 2012-01-16 06:00:01 in Alzheimer's Disease | Brain and Mental Performance | Diet |Vitamins |

Vitamins & Healthy Fats Promote Mental AcuityA diet rich in key vitamins and healthy fats may help older men and women to stay cognitively sharp, as well as reduce brain shrinkage associated with Alzheimer’s Disease. Conversely, a “junk food” diet (characterized by high trans fat intake) predicts lower cognitive scores, as well as reduced total cerebral brain volume. G.L. Bowman, from Oregon Health and Science University (or guide, USA), and colleagues completed a study that specifically measured a wide range of blood nutrient levels and correlated them to performance on mental acuity tests. The researchers enrolled 104 people, average age 87 years, none of whom experienced special risk factors for memory or mental acuity. The team tested 30 different nutrient biomarkers in their blood, and 42 participants also had MRI scans to measure their brain volume. The most favorable cognitive outcomes and brain size measurements were associated with two dietary patterns – high levels of marine fatty acids, and high levels of vitamins B, C, D and E. In contrast, consistently worse cognitive performance was associated with a higher intake of the type of trans-fats found in baked and fried foods, margarine, fast food and other less-healthy dietary choices. The researchers conclude that: "Distinct nutrient biomarker patterns detected in plasma are interwpretable and account for a significant degree of variance in both cognitive function and brain volume.”

Diet, nutrient levels linked to cognitive ability, brain shrinkage

CORVALLIS, Ore. – New research has found that elderly people with higher levels of several vitamins and omega 3 fatty acids in their blood had better performance on mental acuity tests and less of the brain shrinkage typical of Alzheimer's disease – while "junk food" diets produced just the opposite result.

The study was among the first of its type to specifically measure a wide range of blood nutrient levels instead of basing findings on less precise data such as food questionnaires, and found positive effects of high levels of vitamins B, C, D, E and the healthy oils most commonly found in fish.

The research was done by scientists from the Oregon Health and Science University in Portland, Ore., and the Linus Pauling Institute at Oregon State University. It was published today in Neurology, the medical journal of the American Academy of Neurology.

"This approach clearly shows the biological and neurological activity that's associated with actual nutrient levels, both good and bad," said Maret Traber, a principal investigator with the Linus Pauling Institute and co-author on the study.

"The vitamins and nutrients you get from eating a wide range of fruits, vegetables and fish can be measured in blood biomarkers," Traber said. "I'm a firm believer these nutrients have strong potential to protect your brain and make it work better."

The study was done with 104 people, at an average age of 87, with no special risk factors for memory or mental acuity. It tested 30 different nutrient biomarkers in their blood, and 42 participants also had MRI scans to measure their brain volume.

"These findings are based on average people eating average American diets," Traber said. "If anyone right now is considering a New Year's resolution to improve their diet, this would certainly give them another reason to eat more fruits and vegetables."

Among the findings and observations:

  • The most favorable cognitive outcomes and brain size measurements were associated with two dietary patterns – high levels of marine fatty acids, and high levels of vitamins B, C, D and E.
  • Consistently worse cognitive performance was associated with a higher intake of the type of trans-fats found in baked and fried foods, margarine, fast food and other less-healthy dietary choices.
  • The range of demographic and lifestyle habits examined included age, gender, education, smoking, drinking, blood pressure, body mass index and many others.
  • The use of blood analysis helped to eliminate issues such as people's flawed recollection of what they ate, and personal variability in nutrients absorbed.
  • Much of the variation in mental performance depended on factors such as age or education, but nutrient status accounted for 17 percent of thinking and memory scores and 37 percent of the variation in brain size.
  • Cognitive changes related to different diets may be due both to impacts on brain size and cardiovascular function.

The epidemiology of Alzheimer's disease has suggested a role for nutrition, the researchers said in their study, but previous research using conventional analysis, and looking in isolation at single nutrients or small groups, have been disappointing. The study of 30 different blood nutrient levels done in this research reflects a wider range of nutrients and adds specificity to the findings.

The study needs to be confirmed with further research and other variables tested, the scientists said

This work was supported by the National Institutes of Health.

Sunday, January 29, 2012

Hyperbaric Oxygen Tested for Aggressive Brain Cancer

Hyperbaric Oxygen Tested for Aggressive Brain Cancer

Released: 7/22/2011 9:00 AM EDT
Source: Neurological Surgery, P.C.

Newswise — In a unique study, researchers at The Long Island Brain Tumor Center at Neurological Surgery, P.C. are examining whether hyperbaric oxygen therapy – breathing pure oxygen while in a pressurized chamber – may prove a useful addition to the current standard of care for patients newly diagnosed with glioblastoma, an aggressive brain cancer. The Phase II study is currently enrolling participants, and is being conducted at Neurological Surgery, P.C. offices in Nassau and Suffolk Counties, New York, as well as at Winthrop University Hospital, Mineola, NY.

“Malignant glioblastoma is the most aggressive type of brain cancer, and it generally has a poor prognosis,” says neuro-oncologist J. Paul Duic, MD, principal investigator on the study and co-director of The Long Island Brain Tumor Center. “Novel treatment strategies are clearly needed.”

Malignant brain tumors are the second leading cause of cancer deaths in people under 35, and the fourth leading cause of cancer death in people under 54. Glioblastoma is the most common and most aggressive primary (non-metastatic) type of brain cancer. Median survival for glioblastomas is 12-14 months, and only 26 percent of patients survive two years.

Patients enrolled in the study must be newly diagnosed with malignant glioblastoma, and have previously received brain tumor surgery, but not radiation or chemotherapy. All patients in the study will receive the current standard of care for those newly diagnosed with glioblastoma – temozolomide (Temodar®) plus radiation therapy – as well as hyperbaric oxygen therapy.

“We know that these brain tumors prefer a low-oxygen metabolic state, and there is evidence that this metabolic state may contribute to the tumors’ ability to resist the effects of radiation therapy and chemotherapy,” says Jai Grewal, MD, sub-investigator on the study and co-director of The Long Island Brain Tumor Center. “We want to see whether increasing the oxygen concentration of the tumor increases the effectiveness of standard therapy.”

.

Duic and Grewal are also interested in evaluating the effect of this treatment
on patients’ quality of life and stress levels. Participants will be asked to complete several brief questionnaires.

Hyperbaric oxygen has shown some benefit in pre-clinical studies, and in two recent Japanese clinical trials. In the first clinical trial, published in 2006, Ogawa and colleagues found that patients who received radiation therapy immediately after hyperbaric oxygenation, combined with chemotherapy, had longer survival rates, relatively few adverse events and no late toxicities. In 2007, Kohshi and colleagues reported additional survival benefits with minimal additional toxicity for previously treated high-grade glioma patients who were given hyperbaric oxygen combined with stereotactic radiosurgery.

In the current study, which is the only one of its type underway in the U.S., patients will first receive blood and medical imaging tests. They will then be given six weeks of hyperbaric treatments combined with radiation (Monday-Friday) and chemotherapy with temozolomide, which they will take at home daily. They will then have four weeks off treatment, then resume
taking temozolomide on a monthly basis.

Study participants will receive the experimental hyperbaric therapy prior to each radiation
treatment during the initial six weeks of treatment. During the hyperbaric treatment, the patient will lie on a stretcher in a
hyperbaric chamber and breathe oxygen at greater than normal atmospheric pressure. Blood sugar measurements will be taken, and medical imaging tests will also be done.

Patient participation in the study lasts one year, unless the patient cannot tolerate further
treatment or side effects, or shows evidence of tumor
progression. Patients may also voluntarily withdraw from the study.

Study results will be compared with those from the recently published multi-center trial by Stupp and colleagues, which demonstrated that temozolomide, when added to radiation therapy, can prolong the lives of those newly diagnosed with glioblastoma. This study defined the current standard of care.

The Long Island Brain Tumor Center at Neurological Surgery, P.C. provides the most comprehensive care available on Long Island, with state-of-the-art facilities located across Nassau and Suffolk Counties. The Center offers a multi-disciplinary approach to treating brain tumors, provided by a team of more than 20 physicians and surgeons with various sub-specialties. The team works in concert with patients’ medical oncologists and other health care professionals, and treats primary brain and spinal tumors, as well as metastases and CNS lymphoma. The Center is currently conducting two clinical trials.

For more information on this or other brain tumor studies, please call Kerry McConie, RN, (516) 478-0010, or Julia Trojanowski, RN, (631) 864-3900.

About Neurological Surgery, P.C.

Neurological Surgery, P.C. is one of the New York City area’s premier neurosurgical groups, offering patients the most advanced treatments of brain and spine disorders. These include minimally invasive procedures such as stereotactic radiosurgery (Gamma Knife® and CyberKnife®), aneurysm coiling, neuro-endoscopy, spinal stimulators, carotid stents, interventional pain management, microdiscectomy, kyphoplasty, and X-STOP®. The practice’s physicians represent a range of surgical and nonsurgical specialties, combining compassionate care with highly specialized training. They are leaders in the region’s medical community, with appointments as chiefs of neurosurgery in some of Long Island’s best hospitals. NSPC offers eight convenient locations in Queens, Nassau and Suffolk Counties. For more information, call 1-800-775-7784 or visit www.NSPC.com.

Thursday, January 26, 2012

Cognitive Decline Begins in Mid-Life

Cognitive Decline Begins in Mid-Life

Posted on 2012-01-19 06:00:01 in Brain and Mental Performance |
Cognitive Decline Begins in Mid-Life

Whereas global life expectancy is on the rise, the maintenance of cognitive health becomes a public health priority, since poor cognitive status is considered a major disabling condition in old age. Previous studies have established an inverse association between age and cognitive performance, with most studies suggesting little cognitive decline occurs before the age of 60. Archana Singh-Manoux, from Inserm (France), and colleagues completed a large-scale prospective study conducted over a 10-year period, utilizing data from the Whitehall II cohort study involving 10,308 men and women, ages 45 to 70 years the start of the study. Over the 10-year study time frame, each subject was evaluated for memory, vocabulary, reasoning and verbal fluency on three separate occasions. The results showed that cognitive performance (apart from the vocabulary tests) declines with age and more rapidly so as the individual's age increases. The decline is significant in each age group. For example, during the period studied, reasoning scores decreased by 3.6 % for men aged between 45 and 49, and 9.6 % for those aged between 65 and 70. The corresponding figures for women stood at 3.6% and 7.4% respectively. The study authors conclude that: "Cognitive decline is already evident in middle age (age 45-49).”

The onset of cognitive decline begins at 45

Increased life expectancy implies fundamental changes in the composition of populations, with a significant rise in the number of elderly people. These changes are likely to have a massive influence on the life of individuals and on society in general. Abundant evidence has clearly established an inverse association between age and cognitive performance, but the age at which cognitive decline begins is much debated. Recent studies concluded that there was little evidence of cognitive decline before the age of 60.

However, clinical studies demonstrate a correlation between the presence of amyloid plaques in the brain and the severity of cognitive decline. It would seem that these amyloid plaques are found in the brains of young adults.

Few assessments of the effect of age on cognitive decline use data that spans over several years. This was the specific objective of the study led by researchers from Inserm and the University College London.

As part of the Whitehall II cohort study, medical data was extracted for 5,198 men and 2,192 women, aged between 45 and 70 at the beginning of the study, monitored over a 10-year period. The cognitive functions of the participants were evaluated three times over this time. Individual tests were used to assess memory, vocabulary, reasoning and verbal fluency.

The results show that cognitive performance (apart from the vocabulary tests) declines with age and more rapidly so as the individual's age increases. The decline is significant in each age group.

For example, during the period studied, reasoning scores decreased by 3.6 % for men aged between 45 and 49, and 9.6 % for those aged between 65 and 70. The corresponding figures for women stood at 3.6% and 7.4% respectively.

The authors underline that evidence pointing to cognitive decline before the age of 60 has significant consequences.

"Determining the age at which cognitive decline begins is important since behavioural or pharmacological interventions designed to change cognitive aging trajectories are likely to be more effective if they are applied from the onset of decline." underlines Archana Singh-Manoux.

"As life expectancy continues to increase, understanding the correlation between cognitive decline and age is one of the challenges of the 21st Century" she adds.

This research is part of the Whitehall II cohort study and focused on more that 7,000 people over a ten-year period.

Sources

Timing of onset of cognitive decline: results from Whitehall II prospective cohort study
Archana Singh-Manoux research director 1 2 3, Mika Kivimaki professor of social epidemiology 2, M Maria Glymour assistant professor 4, Alexis Elbaz research director 5 6, Claudine Berr research director7 8, Klaus P Ebmeier professor of old age psychiatry9, Jane E Ferrie senior research fellow10, AlineDugravot statistician 1

1Institut National de la Santé et de la Recherche Médicale (INSERM), U1018, Centre for Research in Epidemiology and Population Health, Hôpital Paul Brousse, 94807 Villejuif Cedex, France;

2Department of Epidemiology and Public Health, University College London, London, UK;

3Centre de Gérontologie, Hôpital Ste Périne, AP-HP, France;

4Department of Society, Human Development, and Health, Harvard School of Public Health, Boston, MA, USA;

5Institut National de la Santé et de la Recherche Médicale (INSERM), U708, F-75013, Paris, France;

6UPMC Univ Paris 06, UMR_S 708, F-75005, Paris;

7Institut National de la Santé et de la Recherche Médicale (INSERM) U1061 Université Montpellier 1, Montpellier,France;

8CMRR Languedoc-Roussillon, CHU Montpellier;

9Oxford University Department of Psychiatry, Warneford Hospital, Oxford, UK;

10University of Bristol, Bristol, UK

BMJ
janvier 2012

oxygen

Oxygen is transported across the alveolar membrane and enters plasma. Some is then taken up by hemoglobin and some remains in plasma. Under normal conditions - that is at a standard atmosphere, which is defined as 1013 hPa or 760 mm Hg - 100 ml of arterial blood carries about 19 ml of oxygen as oxyhaemoglobin and only 0.3 ml in solution. Hence, the latter is often ignored. However only the oxygen in the plasma is available for transport through the capillary wall into the tissues and the concentration or tension determines the rate.

Oxygen has to dissociate from hemoglobin to be available. The plasma oxygen tension breathing air with oxygen at a partial pressure (Dalton's Law) of 2 tenths of an atmosphere (21% of 1 atm abs) is about 95 mm Hg. Increasing the oxygen inspired to 100% multiplies the amount in solution by a factor of 5 - hence (Henrys Law) the amount Carried in solution is multiplied by five to 1.5 ml at 3 atm abs it is 4.5 ml per 100 ml blood, which is the normal arterial - venous difference at rest. Hence, all the requirements of the body can be met by the oxygen in the plasma. However, the gradient is what is so important in therapy - over 2000 mm Hg can be achieved - a more than twenty fold increase. Consequently, life can be supported with Blood for a short time and the paper was published in 1959. Used Properly oxygen is the most powerful therapeutic tool in medicine. We Need to ensue our medical students are taught properly but after 25 Years in this school, we have only just established oxygen therapy in the curriculum.

Philip James M.D.
Wolfson Hyperbaric Medicine Unit
University of Dundee
Reprinted with Permission

Sunday, January 22, 2012

Olympic Horse survives barn fire and recovers using HBOT!!

Posted: Sun, Jan. 22, 2012, 3:01 AM

Neville Bardos survives barn fire to become Olympic contender

By Kathy Boccella Inquirer Staff Writer

Boyd Martin riding Neville Bardos at the 2010 World Equestrian Games in Lexington, Ky. "He
JAMES CRISP / Associated Press
Boyd Martin riding Neville Bardos at the 2010 World Equestrian Games in Lexington, Ky. "He's always been overenthusiastic at everything he does," Martin says of the chestnut horse.
1 of 3

Just after 1 a.m. on May 31, the rolling hills of True Prospect Farm in Chester County lit up as a fast-moving fire raced through a barn housing 11 show horses.

Stable workers pulled four to safety, but Neville Bardos, a big chestnut contender for the 2012 Olympics, was trapped in his stall.

With hay and straw ablaze, firefighters thought it too risky to try to save him. Neville's Australian-born trainer, Boyd Martin, had different ideas. He briefly argued with the fire crew, then broke past and ran into the burning barn.

"I held my breath as deeply as I could - I couldn't see anything, but I remember hearing a gurgling," Martin said. "[Neville] was cooped up in a corner and I reached out and found his shoulder and then I found his neck. I got my hand around his neck collar but couldn't move him. He was panicked."

At that moment, Martin's friend and the barn's owner, Phillip Dutton, emerged through the smoke. With Dutton pushing hard from behind, they managed to drag Neville down the aisle and into the crisp May air.

"If I had left it another 30 seconds," Martin said, "it would have all been all over."

With Neville's lungs and airway heavily damaged by smoke, there was no thought that night of whether the horse Martin had named for an Australian gangster would ever compete again - only whether the vets could keep him alive.

Remarkably, the 13-year-old with two white socks and a big white blaze on his face not only resumed competing but was recently awarded the sport's highest honor: Horse of the Year, chosen by the United States Equestrian Federation. Another horse, Sjoerd, shared the award.

Martin, who rode Neville to seventh place in the world's most important cross-country races, the Burghley Horse Trials in England, just three months after the fire, wasn't surprised.

"What that horse did on and off the competition stage last year, I couldn't see a horse in the world that could beat him," he said.

A USEF spokeswoman agreed.

"If he'd gone to live in Boyd's backyard for the rest of his life, the story would have had a happy ending," said Joanie Morris. "But to jump around one of the toughest competitions in the world, that's remarkable."

Six top show horses died in the Memorial Day weekend blaze, which Chester County fire officials say started accidentally near a hay steamer in the center of the barn. Of the five that were rescued, Neville was among the worst off.

Caitlin Silliman, who works for Martin as an assistant rider, was asleep in an apartment above the barn when she and her two roommates heard the horses whinnying and shaking in panic.

They raced downstairs to open as many stall doors as they could, but the horses were too scared to move. They dragged out four before Martin arrived.

"The whole thing lit up very quickly," recalled Silliman.

Her own horse, Catch a Star, suffered burns over 50 percent of her body.

Neville, she said, was "really lucky" to escape serious burning. Silliman was even luckier; her apartment shared a wall with the hayloft.

The horse's worst injury was to his upper airway and lungs, said Samantha Hart, the veterinarian who saw him for almost two weeks at the University of Pennsylvania's New Bolton Center. He then was treated in a hyperbaric oxygen chamber at Fair Hill Equine Center.

Hart said the horse's injuries could have ended his career, but "he's definitely a fighter. He's an amazing horse."

That's hardly the way anyone would have described Neville when Martin bought him for $800 as a washed-up 3-year-old racehorse destined for the slaughterhouse - his first brush with death.

"I thought he looked like a real athlete," said Martin, who planned to train him as a jumper and sell him.

But the horse turned out to be a handful and a "wind sucker," a bad habit in which horses bite and chew on whatever they can get their mouths on and suck up air, which can cause colic.

"I was stuck with him," said Martin, who named him after another hothead, a notorious Australian gangster.

Silliman is more blunt: "He's wild. A lot of the girls at the barn won't even walk him. He gets spooked and runs and tries to buck you off. He's a very unpredictable horse."

But he's also fast and strong and a hard worker. Neville's sport, eventing, consists of three parts: a cross-country obstacle course, show jumping, and dressage. Slow on the track, Neville rockets around the open fields of a cross-country course.

"I'm sure he was put on this earth to do it," said his trainer, who sold him to a 10-member syndicate in 2010 for $150,000.

Dressage is his soft spot. The series of controlled movements requires elegance, precision, and suppleness, qualities that don't mesh with Neville's exuberance.

"He's always been overenthusiastic at everything he does," Martin said. "He almost tries too hard to please."

After a rough start, Neville started winning events and was short-listed for the 2008 Beijing Olympics. In 2010, he was named to the U.S. team for the World Equestrian Games and ended up being the highest-placed U.S. horse.

Now Martin and his wife, Silvi, a dressage trainer and rider, are waiting to hear about this summer's Olympic Games in London, which will commemorate the centennial of the equestrian event. Martin had been a contender for the Australian team for many years but now will try for a berth with the United States.

"That's the pinnacle of our sport," he said of the Olympics.

And riding to gold atop his miracle horse, he said, "would be huge."

Saturday, January 21, 2012

OXYGEN UPTAKE IN MITOCHONDRIA

OXYGEN UPTAKE IN MITOCHONDRIA

If there's one thing that mitochondria thrive on, its oxygen. All of it is consumed by cytochrome oxidase, the last enzyme in the electron transport chain which drives ATP production. If cells relied on diffusion alone to supply them with their oxygen needs, then there would not be enough to keep up with demand. So oxygen carrying molecules, such as haemoglobin and myoglobin, evolved to transport oxygen to where it is needed. However as Jonathan and Beatrice Wittenberg explain, researchers know very little about the conditions necessary for oxygen to reach cytochrome oxidase (p. 2082).

As oxygen travels through the body it exerts a pressure in the mixture of gases in the lungs, or in solution, known as the partial pressure. Oxygen bound to haemoglobin in the blood diffuses down a steep pressure gradient into tissues as blood travels through capillaries. Next oxygen diffuses into the mitochondria. By reducing the oxygen pressure to levels below which mitochondria would not get enough oxygen without the help of haemoglobins, the Wittenbergs hoped to find the oxygen partial pressure necessary for oxygen uptake by mitochondria from hard working pigeon hearts. Also, would myoglobin in the heart muscle need to bind to mitochondria to deliver oxygen? To extract mitochondria for their study, the team delicately ground up the heart muscle tissue with a homogeniser and dissolved away the toughest tissue with enzymes; then, they released the mitochondria from the cell fragments and put them in a nourishing solution.

To show that myoglobin doesn't need to bind to the surface of mitochondria to deliver its oxygen, they used six different haemoglobins in the solution to deliver the oxygen: one each from horse, an insect, and soy bean, and three from molluscs. Each binds and releases oxygen at very different rates. Using a method called spectrophotometry, where a light is shone through biological samples and the light absorbed at each wavelength is measured, the team could tell how oxygenated the haemoglobins were since they absorb different light wavelengths depending on how much oxygen they are carrying. Despite differences in the speed with which oxygen bound to and was released from the haemoglobins, the mitochondria still took up oxygen at the same rate, showing that the haemoglobins didn't bind to the surface to deliver their cargo.

To find what oxygen partial pressure kept cytochrome oxidase functioning normally, they measured the saturation of each of the haemoglobins with oxygen and how it decreased as the mitochondria used oxygen up. From this they calculated oxygen pressure, which is directly related to haemoglobin saturation. When oxygen uptake was half its maximal rate, they found that the oxygen pressure at the surface of the mitochondria was very similar for all the haemoglobins, around 0.0053 kPa, despite their different reaction kinetics. This is much smaller than the pressure measured previously in working hearts, around 0.32 kPa. This means that even when a heart muscle is working flat out, such as during flight, the mitochondria will still have plenty of oxygen available to generate ATP.

Because oxygen uptake also levelled out as they increased the concentrations of the haemoglobins, the team suspect that there is just enough myoglobin present to support the cell, but not more, indicating that cells optimise oxygen delivery. `The results were not unexpected', Jonathan Wittenberg explains. Despite this, he says, `there is still a lot we don't understand about oxygen transport in heart and muscle'.

References

Wittenberg, J. B. and Wittenberg, B. A. (2007). Myoglobin-enhanced oxygen delivery to isolated cardiac mitochondria. J. Exp. Biol. 210,2082 -2090.[Abstract/Free Full Text]

Thursday, January 19, 2012

Oxygen; the new growth factor?


Oxygen; the new growth factor?

In recent years our understanding of the intercellular communication of healing has increased considerably. Cells within a wound receive a myriad of signals from their environment – the sum of which govern the activity of a cell. The term “cytokine” is applied to those substances which function as cellular signals. Growth factors are a subclass of cytokines that specifically stimulate the proliferation of cells. This stimulation may occur through several different mechanisms. For example, some growth factors have chemo-tactic activities that attract fibroblasts and inflammatory cells, some act as mitogens, stimulating cell division, and some effect the production and degradation of the extra-cellular matrix. All of these phenomena are the end result of a cytokine (growth factor) signaling the cell nucleus to produce proteins, which account for the observed activities. A clear understanding of growth factor physiology carries the promise of clinical advances in wound management. Currently one cytokine, Platelet Derived Growth Factor, is in clinical use for the management of problem wounds. As our knowledge of these substances expands, other growth factors will be added to our clinical armamentarium for the management of non-healing wounds.

Non-healing wounds can also be managed by optimizing the metabolic requirements of healing, e.g. protein, trace elements, and oxygen. The most frequent common denominator in non-healing wounds is inadequate tissue oxygenation, which impairs healing and host defenses. Correction of such hypoxia by means of revascularization or hyperbaric oxygen therapy results in healing for most patients. Conventional wisdom suggests that oxygen is just a metabolite and therefore healing, in these circumstances, is simply a reflection of having sufficient oxygen to meet the energy demands of wound repair. However, some exciting evidence is now emerging to suggest that oxygen serves a dual role as both a metabolite and a growth factor. The conceptualization of oxygen as a growth factor has considerable relevance to the field of hyperbaric oxygen therapy.

The idea of oxygen acting as a cell signal has already been established in the setting of hypoxia. As an example, gene expression for erythropoietin production is largely proportional to the pO2 level in the kidney. It has been proposed that cells in a non-healing wound may respond to hyperbaric therapy because the supra-physiologic elevation of tissue oxygen serves as a trigger signaling that enough oxygen is in the environment to proceed with normal healing.1 Subsequent daily exposure to the threshold oxygen level reinforces this signal and results in gene expression of the protein building blocks required for healing. Teleologically, it makes sense for cells to conserve resources until the environmental signals are strong enough and consistent enough to activate the cell nucleus and begin the healing process.

This past year two separate groups of investigators have published findings that support this concept of oxygen as a growth factor. Following a single one-hour exposure to hyperbaric oxygen, Hehenberger, et al. (1997) demonstrated a dose dependent stimulation of normal in vitro fibroblasts with a peak increase in cell proliferation at 2.5 ATA O2. The dose-dependent effect of a single 1-hour exposure to oxygen suggests a pharmacologic effect of oxygen on cells, as opposed to an increased metabolic availability of oxygen. These findings suggest, therefore, that a single brief exposure to hyperbaric oxygen on a daily basis provides a strong initiating signal for the intracellular events that culminate in cell proliferation, while sustained hyperoxia has the opposite effect.

In a study of in vitro fibroblast proliferation using tritium-labeled thymidine, Tompach, et al., found that a single dose of HBO (2.4 ATA for 120 minutes) produced a sustained stimulation of fibroblasts for 72 hours.3 If a second exposure to HBO was given on the same day there was no additional increase in cell proliferation. Similarly, cultured endothelial cells remained stimulated for 72 hours following a single 15-minute exposure to HBO. Again, these findings suggest that we must reconsider oxygen as being more than just a metabolite.

This new paradigm of oxygen as a growth factor is consistent with the clinical observation that a BID dosing of HBO appears to offer no clear benefit over a QD dosing schedule for the treatment of chronic wounds. As our understanding of oxygen physiology increases, we will be in a better position to determine the optimal dosing of oxygen in both its metabolic and stimulatory roles.

References:

1. Siddiqui A, Davidson JD, Mustoe TA. Ischemic tissue oxygen capacitance after hyperbaric oxygen therapy: A new physiologic concept. Plastic Reconstructive Surgery 1997; 99:148-69.

2. Hehenberger K, Brismar K, Folke L, Gunnar K. Dose-dependent hyperbaric oxygen stimulation of human fibroblast proliferation. Wound Rep Reg 1997; 5:147-50.

3. Tompach PC, Lew D, Stoll JL. Cell response to hyperbaric oxygen treatment. Int J Oral Maxillofac Surgery 1997; 26: 82-86.

Printed with Permission

Rapid Recovery Hyperbarics

9439 Archibald Ave., #104 909-477.4545

www.hbot4u.com

“Rapid Recovery Hyperbarics answers to a higher authority”

Tuesday, January 17, 2012

Speak Smooth


Speak Smooth by SpeechNutrients is a winner in our house! Audrey (7) loves it as does everyone else!

Oils in a smoothy form? Amazing!

Kara Bolton
Kara@speechnutrients.com


www.speechnutrients.com
for more information!